LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in LianBio as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +7 vs. Q1 2022
- Shares held
- 86.6M
- +664.1K (+0.8%) vs. Q1 2022
- Total value
- $187.1M
- −$131.6M (−41.3%) vs. Q1 2022
- New holders
- 13
- 11 more added
- Sold out
- 6
- 10 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,001 | $2.00K | 0.00% | −3,018−75.1% | Reduced |
| Bank of America Corp | 1,003 | $2.00K | 0.00% | +929+1,255.4% | Added |
| Tower Research Capital LLC (TRC) | 1,157 | $3.00K | 0.00% | −4,746−80.4% | Reduced |
| Commonwealth Equity Services, LLC | 10,830 | $23.0K | 0.00% | +10,830 | New |
| Raymond James & Associates | 10,650 | $23.0K | 0.00% | +10,650 | New |
| Alliancebernstein L.P. | 11,500 | $25.0K | 0.00% | −1,507,469−99.2% | Reduced |
| Virtu Financial LLC | 11,740 | $25.0K | 0.00% | +11,740 | New |
| Dynamic Technology Lab Private Ltd | 11,900 | $25.0K | 0.00% | +11,900 | New |
| HighTower Advisors, LLC | 18,900 | $40.0K | 0.00% | +18,900 | New |
| Vident Investment Advisory, LLC | 19,913 | $43.0K | 0.00% | 00.0% | Unchanged |
| Old Well Partners, LLC | 32,200 | $70.0K | 0.06% | +13,000+67.7% | Added |
| Cubist Systematic Strategies, LLC | 32,300 | $70.0K | 0.00% | +32,300 | New |
| Bailard, Inc. | 47,597 | $103.0K | 0.00% | +10,697+29.0% | Added |
| Cornercap Investment Counsel Inc | 52,140 | $113.0K | 0.02% | +52,140 | New |
| Renaissance Technologies LLC | 60,900 | $132.0K | 0.00% | +24,376+66.7% | Added |
| Alps Advisors Inc | 64,228 | $139.0K | 0.00% | −45,991−41.7% | Reduced |
| Manufacturers Life Insurance Company, The | 77,784 | $170.3K | 0.00% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 79,220 | $171.0K | 0.00% | +29,715+60.0% | Added |
| Gsa Capital Partners LLP | 96,584 | $209.0K | 0.03% | +96,584 | New |
| Millennium Management LLC | 113,201 | $245.0K | 0.00% | −74,117−39.6% | Reduced |
| MYDA Advisors LLC | 120,000 | $259.0K | 0.11% | +34,000+39.5% | Added |
| 22NW, LP | 141,223 | $305.0K | 0.16% | +141,223 | New |
| TD Asset Management Inc | 154,919 | $335.0K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 173,460 | $375.0K | 0.00% | 00.0% | Unchanged |
| Casdin Capital, LLC | 206,415 | $446.0K | 0.04% | 00.0% | Unchanged |
| Marshall Wace, LLP | 223,391 | $483.0K | 0.00% | +196,934+744.4% | Added |
| Altium Capital Management LP | 315,191 | $681.0K | 0.29% | +315,191 | New |
| Alyeska Investment Group, L.P. | 329,186 | $711.0K | 0.01% | −10,056−3.0% | Reduced |
| Logos Global Management LP | 394,486 | $852.0K | 0.16% | −18,351−4.4% | Reduced |
| Citigroup Inc | 448,519 | $969.0K | 0.00% | −85,276−16.0% | Reduced |
| Affinity Asset Advisors, LLC | 450,000 | $972.0K | 0.53% | +125,000+38.5% | Added |
| Farallon Capital Management, L.L.C. | 500,000 | $1.08M | 0.01% | +500,000 | New |
| Hudson Bay Capital Management LP | 713,743 | $1.54M | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 837,173 | $1.81M | 0.00% | +128,867+18.2% | Added |
| SCHF (Gpe), LLC | 937,500 | $2.02M | 2.99% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,032,084 | $2.23M | 0.00% | +1,032,084 | New |
| BlackRock Inc. | 1,032,083 | $2.23M | 0.00% | +1,032,083 | New |
| Price T Rowe Associates Inc | 2,126,878 | $4.59M | 0.00% | −115,511−5.2% | Reduced |
| Vida Ventures Advisors, LLC | 2,282,084 | $4.93M | 4.17% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 3,314,173 | $7.16M | 0.52% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,564,173 | $7.70M | 0.04% | +2,064,173+137.6% | Added |
| Ra Capital Management, L.P. | 4,622,574 | $9.98M | 0.27% | −3,032,441−39.6% | Reduced |
| VR Adviser, LLC | 5,378,341 | $11.6M | 2.29% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 56,560,211 | $122.2M | 3.84% | +240,251+0.4% | Added |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −275,007−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −43,185−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −33,491−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |